Generic Names of Some Trade Name Drugs, THE MERCK MANUAL OF HEALTH & AGING Committed to Providing Medical Information Table of Contents Index Enlarge Text Reset Text Shrink Text -- Buy the Book Learn about participating in clinical trials at this government website: www.clinicaltrials.gov - APPENDIX I - Drug Names: Generic and Trade TOPICS - Introduction -~ Some Trade Names of Generic Drugs -~ Generic Names of Some Trade Name Drugs - Generic Names of Some...
Some Trade Names of Generic Drugs, THE MERCK MANUAL OF HEALTH & AGING Committed to Providing Medical Information Table of Contents Index Enlarge Text Reset Text Shrink Text -- Buy the Book Learn about participating in clinical trials at this government website: www.clinicaltrials.gov - APPENDIX I - Drug Names: Generic and Trade TOPICS - Introduction -~ Some Trade Names of Generic Drugs-~ Generic Names of Some Trade Name Drugs - Some Trade Names of...
Supraventricular Tachycardia - Quest Diagnostics Patient Health Library Supraventricular Tachycardia Overview Atrial fibrillation is the most common type of supraventricular tachycardia.
Digoxin for mitral valve regurgitation - [Medication] - Quest Diagnostics Patient Health Library Digoxin for mitral valve regurgitation Examples Brand Name Chemical Name Lanoxicaps, Lanoxin digoxin Digoxin is used to treat mitral valve regurgitation when atrial fibrillation is present or when there are symptoms of heart failure due to left ventricle dysfunction.Digoxin is used in mitral valve regurgitation when atrial fibrillation...
Digoxin for heart failure - [Medication] - Quest Diagnostics Patient Health Library Topic Contents - Examples - How It Works - Why It Is Used - How Well It Works - Side Effects - What To Think About - References Digoxin for heart failure - [Medication] - Quest Diagnostics Patient Health Library Digoxin for heart failure - [Medication] - Quest Diagnostics Patient Health Library AI, aortic insufficiency, aortic regurgitation, aortic valve regurgitation,...
Digoxin for fast heart rates - [Medication] - Quest Diagnostics Patient Health Library Digoxin for fast heart rates Examples Brand Name Chemical Name Lanoxicaps, Lanoxin digoxin Crystodigin digitoxin How It Works Digoxin helps slow the heart rate by reducing the number of electrical impulses that pass through (but do not originate in) the atrioventricular (AV) node into the lower heart chambers (ventricles).
Digoxin for atrial fibrillation - [Medication] - Quest Diagnostics Patient Health Library Topic Contents - Examples - How It Works - Why It Is Used - How Well It Works - Side Effects - What To Think About Digoxin for atrial fibrillation - [Medication] - Quest Diagnostics Patient Health Library Digoxin for atrial fibrillation - [Medication] - Quest Diagnostics Patient Health Library Heart and circulation, Heart problems, Abnormal Heart Rhythms, abnormal...
1996 and Older - New Drug Application (NDA) New Drug Approval Packages These drug approval packages, sorted by product trade name, are supplied by the CDER Freedom of Electronic Information Office
http://www.fda.gov/cder/orange/appendix_a.txt ACTHAR GEL, CORTICOTROPIN H.R.-50, HYDROCHLOROTHIAZIDE HABITROL, NICOTINE (OTC) HALCION, TRIAZOLAM HALDOL SOLUTAB, HALOPERIDOL HALDOL, HALOPERIDOL HALDOL, HALOPERIDOL DECANOATE HALDOL, HALOPERIDOL LACTATE HALDRONE, PARAMETHASONE ACETATE HALFAN, HALOFANTRINE HYDROCHLORIDE HALOG, HALCINONIDE HALOG-E, HALCINONIDE HALOPERIDOL DECANOATE, HALOPERIDOL DECANOATE HALOPERIDOL INTENSOL,...
http://www.fda.gov/cder/dmf/text/4Q2003ACTIVETYPE2TEXT.txt "PSEUDOEPHEDRINE HYDROCHLORIDE AS MFG IN HESHOU COUNTY, XINJIANG, CHINA." 15333 30-Mar-01 DEGUSSA-HULS AG "N6-TRIFLUORACETYL-L-LYSYL-L-PROLINE MANUFACTURED IN HANAU AND RADEBEUL, GERMANY." 15335 15-Mar-01 RP SCHERER NORTH AMERICA "LANOXICAPS (0.5, 0.10, AND 0.20MG) SOFTGEL CAPSULES AS MFG IN ST.PETERSBURG, FL." 15337 19-Mar-01 SPI PHARMA "MAGNESIUM HYDROXIDE PASTE/POWDER USP AS...
lanoxicaps drug review FDA Home Page | CDER Home Page | CDER Site Info | Contact CDER | What's New @ CDER - Search - -Drug Review Package Lanoxicaps (Digoxin Solution Capsules) Company:- Burroughs Wellcome Company Application No.:- 18118 Approval Date:-6/26/82 Approval Letter(s) - Printed Labeling - - Medical Review(s) - Part 1 - Part 2 - Chemistry Review(s) - - Pharmacology Review(s) - -...
http://www.fda.gov/cder/ogd/rld/RLD_LABELING_APPROVED_JUL_1998.HTML Firm Date QUINAGLUTE DURA-TABS Quinidine gluconate ER tablets 16-647 S-035 Berlex 1-July-1998 CARDIOQUIN Quinidine polygalacturonate tablets 11-642 S-011 Purdue Frederick 1-July-1998 LIPITOR Atorvastatin calcium tablet 20-702 S-003 Warner Lambert Export Ltd 10-July-1998 ORTHO-NOVUM 1/50 28 Mestranol/norethindrone tablets 16-709 S-123 RW Johnson 10-July-1998 ORTHO-NOVUM 1/50 21...
http://www.fda.gov/cder/drug/infopage/unithroid/optrare.pdf Associate Director for Medication Error Prevention Office of Postmarketing Drug Risk Assessment (OPDRA) 9 ATTACHMENT 1 TABLE 2 Postmarketing Safety Reports of Medication Errors Associated with levothyroxine Intended product Dispensed product Outcome Cause( s) AERS # Incorrect Dose (n= 8) Synthroid 50 mcg QD Synthroid 50 mcg QID Hospitalized Misinterpretation M1759043 Levothyroxine 0...
http://www.fda.gov/cder/drug/infopage/unithroid/optrare.pdf page 9
FDA Drug Approvals List- July 1998 Drug Approvals for July 1998 Definitions and Notes July 1998 Original New Drug Applications Original Application #: 020822 Approval Date: 17-JUL-98 Trade Name: CELEXA Chemical Type: 1 Therapeutic Potential: S Dosage Form: TABLET Applicant: FOREST LABORATORIES INC Active Ingredient(s): CITALOPRAM HYDROBROMIDE OTC/RX Status: RX Indication(s): TREATMENT OF DEPRESSION Original...
DDPA June 1996 74-515 TIMOLOL MALEATE AKRON TIMOLOL MALEATE 17-JUN-96 (SOLUTION) DECATUR, IL EQ 0.25% BASE 62525 (BETA ADRENERGIC BLOCKER) 74-516 TIMOLOL MALEATE AKRON TIMOLOL MALEATE 17-JUN-96 (SOLUTION) DECATUR, IL EQ 0.5% BASE 62525 (BETA ADRENERGIC BLOCKER) 16-096 MINTEZOL MSD THIABENDAZOLE 03-JUN-96 (TABLET, CHEWABLE) WEST POINT, PA 500MG 19486 (LABELING REVISION -- INDICATIONS AND USAGE;...
http://www.fda.gov/cder/drug/infopage/unithroid/optrare.pdf page 4
